Jnana Therapeutics Reports Positive Topline Results from Phase 1a Clinical Study of JNT-517, a Potential First-in-Class Oral Treatment for PKU
May 31, 2023 07:00 ET
|
Jnana Therapeutics, Inc.
JNT-517 demonstrated proof of mechanism and was safe and well tolerated in healthy volunteers Results support advancement to Phase 1b study in individuals with PKU; study now open for enrollment ...
Coave Therapeutics announces Positive 12-months Data from Ongoing Phase I/II Clinical Trial of CTx-PDE6b in Patients with Retinitis Pigmentosa Caused by Bi-allelic Mutations in PDE6b
May 31, 2023 06:00 ET
|
Coave Therapeutics
CTx-PDE6b demonstrated clinically meaningful benefit in visual functions at the highest dose and exhibits a good safety profile Positive results from the study to date support preparations for a...
Global Biochips Market to Grow by $43.27 Billion During 2023-2027
May 31, 2023 05:53 ET
|
Research and Markets
Dublin, May 31, 2023 (GLOBE NEWSWIRE) -- The "Global Biochips Market 2023-2027" report has been added to ResearchAndMarkets.com's offering.The biochips market is forecast to grow by USD 43,273.01...
Anocca raises SEK 400 million for large-scale development of cancer cell therapies
May 31, 2023 01:30 ET
|
Anocca AB
SÖDERTÄLJE, Sweden, May 31, 2023 (GLOBE NEWSWIRE) -- Anocca AB today announces that the company has successfully raised SEK 400 million through an equity financing round led by AMF and...
Exagen Inc. to Participate in the William Blair 43rd Annual Growth Stock Conference
May 30, 2023 09:00 ET
|
Exagen Inc.
SAN DIEGO, May 30, 2023 (GLOBE NEWSWIRE) -- Exagen Inc. (Nasdaq: XGN), a leading provider of autoimmune testing solutions, today announced its participation in the William Blair 43rd Annual Growth...
Digital PCR Market Share to Witness Stunning Growth at a CAGR of 15.3% by 2032: Market.us Analysis
May 30, 2023 08:08 ET
|
Market.Us
New York, May 30, 2023 (GLOBE NEWSWIRE) -- The Digital PCR Market Size accounted for USD 450 Million in 2022 and is estimated to garner a market size of USD 1,803 Million by 2032 rising at a CAGR of...
Mydecine Innovations Group Files Prospectus Supplement, Announces Closing Under Share Subscription Agreement and Provides Update on Its Board of Directors
May 29, 2023 19:42 ET
|
Mydecine Innovations Group Inc.
VANCOUVER, British Columbia, May 29, 2023 (GLOBE NEWSWIRE) -- Mydecine Innovations Group Inc. (“Mydecine” or the “Company”) (NEO:MYCO) (OTC:MYCOF) (FSE:0NFA) a biotechnology company engineering the...
Monoclonal Antibodies Market Sales are Anticipated to reach US$ 588.0 Billion by 2032, Increasing at 11.8% CAGR: Market.us Report
May 26, 2023 01:50 ET
|
Market.Us
New York, May 26, 2023 (GLOBE NEWSWIRE) -- The Monoclonal Antibodies Market size was valued at USD 198.2 Bn in 2022. The total market revenue is expected to grow at a CAGR of 11.8%, reaching...
KAIST and Checkmate Capital Complete Investment in Bredis Healthcare
May 25, 2023 18:00 ET
|
Checkmate Capital
Investment Accelerates Bredis’ Capacity Expansion, Integrated Platform Development and Commercialization in Korea Further Announcement of Bredis’ Agreements with Major University Hospitals SEOUL,...
PDS Biotech Announces Interim Data Demonstrates 12-Month Survival Rate of 87% with PDS0101 in Combination with KEYTRUDA® (pembrolizumab) for Head and Neck Cancer Patients
May 25, 2023 17:00 ET
|
PDS Biotechnology Corporation
Interim data being presented at ASCO 2023 Annual Meeting Demonstrated median progression-free survival (PFS) of 10.4 months Demonstrated 12-month overall survival (OS) rate of 87.1%A disease control...